Advances in drug discovery and development

Stuart Haynes.mp4
Hear about "Extensive Sequence and Structural Evolution of Inhibitory Antibodies to Arginase2 Enabled by an Unbiased Approach to Affinity Maturation" from Stuart Haynes, our Deputy Laboratory Head at our Antibody Alliance Laboratory (the Alliance ended in 2024). The talk was given as part of Technology Networks' "Advances in Drug Discovery and Development" symposium which took place on October 26-27.